SubsidieMeestersAntibacterial wound dressing based on advanced nanotechnology to improve the efficiency of wound care
Nanordica aims to revolutionize wound care with an advanced antibacterial dressing that significantly reduces infections, lowers healthcare costs, and improves patient outcomes.
Projectdetails
Introduction
Infected wounds are a major cause of limb amputations among patients with chronic diseases like diabetes. 10 million amputations occur annually, causing 100 billion additional healthcare costs. During the COVID-19 pandemic, the number of amputations rose tenfold due to the low efficacy of current solutions.
Product Development
Nanordica develops an advanced Antibacterial Wound Dressing (AWD) to prevent and treat wound infections. We have demonstrated that our AWD removes bacterial infection 8 times better than the current best solutions. Our value propositions are high efficacy and low cost.
Market Overview
The global antibacterial wound dressing market is projected to reach 4.2 billion in 2026 at a CAGR of 5.7%.
Business Model
Our business model is B2B, using distributors to reach our customers, i.e., hospitals. We have a priority for intellectual property and have initiated a pilot clinical trial at the largest Estonian hospital.
Mission
Our mission is to bring AWD to the market to improve the outcome of wound infections, lower healthcare costs, and help hundreds of millions of patients.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.402.750 |
| Totale projectbegroting | € 3.432.500 |
Tijdlijn
| Startdatum | 1-4-2023 |
| Einddatum | 31-3-2026 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- NANORDICA MEDICAL OUpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Personalised Bioelectronics for Epithelial RepairProBER aims to develop personalized bioelectronic wound dressings using conformal DC electrodes to enhance healing speed and efficiency in chronic wounds, preparing for clinical studies. | ERC POC | € 150.000 | 2023 | Details |
A Paradigm Shift in Health Monitoring with Electrospun Enzymatic NeomaterialsWOUNDSENS aims to develop innovative wearable biosensors integrated into smart wound dressings to enhance chronic wound monitoring and improve patient quality of life. | EIC Pathfinder | € 2.934.318 | 2023 | Details |
New generation of bioactive coating for intravenous catheters and implantable medical devices to prevent infections and thrombosisDeveloping a novel coating technology using layer-by-layer cross-linked nanogels to prevent thrombosis and bloodstream infections in implantable medical devices, aiming for market readiness. | EIC Transition | € 2.476.343 | 2024 | Details |
Nanoengineered photoactivated drug-free antimicrobial precision treatment for chronic skin woundsThis project aims to validate a drug-free PHOTOCURE wound patch that uses photocatalytic activity to effectively eradicate antibiotic-resistant biofilms in chronic skin infections like diabetic foot ulcers. | ERC POC | € 150.000 | 2024 | Details |
Personalised Bioelectronics for Epithelial Repair
ProBER aims to develop personalized bioelectronic wound dressings using conformal DC electrodes to enhance healing speed and efficiency in chronic wounds, preparing for clinical studies.
A Paradigm Shift in Health Monitoring with Electrospun Enzymatic Neomaterials
WOUNDSENS aims to develop innovative wearable biosensors integrated into smart wound dressings to enhance chronic wound monitoring and improve patient quality of life.
New generation of bioactive coating for intravenous catheters and implantable medical devices to prevent infections and thrombosis
Developing a novel coating technology using layer-by-layer cross-linked nanogels to prevent thrombosis and bloodstream infections in implantable medical devices, aiming for market readiness.
Nanoengineered photoactivated drug-free antimicrobial precision treatment for chronic skin wounds
This project aims to validate a drug-free PHOTOCURE wound patch that uses photocatalytic activity to effectively eradicate antibiotic-resistant biofilms in chronic skin infections like diabetic foot ulcers.